A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Participants · Participants With Mild Hepatic Impairment · Participants With Moderate Hepatic Impairment
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China